Omeprazole and gut bacteria in adults with obesity and acid reflux
Treatments studied
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests if the medicine omeprazole, commonly used for acid reflux, changes the bacteria in the gut. It may help doctors understand how this treatment affects people with obesity and reflux, and why some people might benefit more than others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 65 years old.
- You have obesity (body mass index of 30 or higher).
- You have mild or moderate acid reflux symptoms like heartburn or regurgitation.
- If you are a woman, you have gone through menopause (no period for at least 12 months).
- You have not taken certain acid-reducing medicines (like omeprazole or similar) in the last 8 weeks, and no antibiotics in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how following specific diet and behavior changes affects symptoms of acid reflux (heartburn/regurgitation) in everyday life. It may help you understand what lifestyle steps improve reflux and how symptoms change over time.
This study tests a comprehensive program that combines diet and lifestyle changes to help people with chronic acid reflux (heartburn, acid regurgitation, or chest pain) feel better. It looks at how these changes can improve your overall health and reduce symptoms.
This study compares two common weight-loss surgeries (gastric bypass and sleeve gastrectomy) to see which is better at treating acid reflux in people with obesity. If you have reflux and are considering surgery, this trial will randomly put you in one of the two surgery groups.
This study looks at how proton pump inhibitors (PPIs), a type of medicine that reduces stomach acid, affect the natural bacteria in the gut of children and teenagers. It may help us understand if PPIs change gut health, which could guide future treatment decisions.
This trial is testing a device called RefluxStop™ that is implanted during keyhole surgery to treat acid reflux (GERD). The study will check how safe and effective the device is for people with long-term GERD, and it aims to help reduce heartburn and other reflux symptoms.
This study looks at how being obese relates to heartburn and acid reflux (GERD). If you are obese, joining may help researchers understand the connection better, even though there is no specific treatment being tested.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.